Development of disorder-specific normative data for growth in children with cerebral palsy.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 08 01 2019
accepted: 01 03 2019
revised: 23 02 2019
pubmed: 17 3 2019
medline: 25 12 2019
entrez: 17 3 2019
Statut: ppublish

Résumé

The purpose of this study was to create growth-percentiles for Caucasian children with cerebral palsy (CP). The studied parameters were height and age. In a retrospective analysis, we converted measurements collected in our center to create disorder-specific percentiles of normative data. Patients were stratified due to sex (male and female) and to mobility levels using the gross motor function classification system (GMFCS) (A = walking; GMFCS I-III, B = non walking; GMFCS IV-V) into four groups. In total, 2363 measurements in patients 0-18 years were collected. The mean age for group "Am" was 6.8 years (n = 862), group "Bm" 7.6 years (n = 563), group "Af" 7.7 years (n = 600), and group "Bf" 8.2 years (n = 366). The created percentiles for all groups were below the reference percentiles for healthy Caucasian children (KiGGS). The median curve for children with GMFCS levels I-III is slightly above the 3rd percentile, whereas the 50th percentile for GMFCS levels IV-V is mostly below the 3rd KiGGS centile.Conclusion: In conclusion, children with cerebral palsy are smaller than healthy children. The difference between 50th percentile of CP patients compared to healthy children supports the need for the use of disorder-specific growth charts. Those charts can help clinicians differentiate growth disorders in patients with CP. What is Known: • Children with cerebral palsy are shorter than healthy children and height is influenced by level of ambulation. • Currently, only reference percentiles of American children with mixed ethical backgrounds are available to evaluate growth. What is New: • This paper presents disorder-specific reference percentiles for longitudinal growth of Caucasian children with cerebral palsy depending on motor function. • These percentiles allow to asses longitudinal growth in children with cerebral palsy to detect other additional diseases impairing growth.

Identifiants

pubmed: 30877384
doi: 10.1007/s00431-019-03360-5
pii: 10.1007/s00431-019-03360-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

811-822

Subventions

Organisme : Koeln Fortune Program / Faculty of Medicine, University of Cologne
ID : 225/2015
Organisme : Research grant from IPSEN PHARMA GmbH
ID : 58035/030

Références

Am J Clin Nutr. 2000 Aug;72(2 Suppl):521S-8S
pubmed: 10919954
Stat Med. 2000 Nov 15;19(21):2943-62
pubmed: 11042625
Dev Med Child Neurol. 2000 Dec;42(12):816-24
pubmed: 11132255
Stat Med. 2001 Apr 30;20(8):1259-77
pubmed: 11304741
J Am Diet Assoc. 2002 Mar;102(3):361-73
pubmed: 11902369
Pediatr Res. 2002 Aug;52(2):137-47
pubmed: 12149488
Arch Phys Med Rehabil. 1961 Jun;42:475-81
pubmed: 13777130
Arch Phys Med Rehabil. 1960 Apr;41:131-5
pubmed: 13834415
Endocr Rev. 2003 Dec;24(6):782-801
pubmed: 14671005
Stat Med. 1992 Jul;11(10):1305-19
pubmed: 1518992
Dev Med Child Neurol. 1992 May;34(5):379-88
pubmed: 1592191
Pediatrics. 2006 Sep;118(3):1010-8
pubmed: 16950992
Dev Med Child Neurol. 2007 Mar;49(3):167-71
pubmed: 17355471
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Stat Med. 1991 May;10(5):675-90
pubmed: 2068420
Pediatrics. 2011 Aug;128(2):e299-307
pubmed: 21768315
PLoS One. 2012;7(8):e42506
pubmed: 22916131
Stat Methods Med Res. 2014 Aug;23(4):318-32
pubmed: 23376962
Am J Phys Med Rehabil. 2013 Oct;92(10):912-9
pubmed: 23739271
Indian Pediatr. 2014 Jan;51(1):37-43
pubmed: 24561465
Arq Neuropsiquiatr. 2014 May;72(5):360-7
pubmed: 24863512
Osteoporos Int. 2015 Jan;26(1):141-50
pubmed: 25119201
Pediatrics. 2015 Jan;135(1):e126-35
pubmed: 25489013
PLoS One. 2016 Jun 09;11(6):e0157277
pubmed: 27280591
Pediatrics. 2016 Oct;138(4):
pubmed: 27604185
N Engl J Med. 1988 Mar 10;318(10):599-602
pubmed: 3344006
Dev Med Child Neurol. 1986 Dec;28(6):729-33
pubmed: 3817311
Eur J Pediatr. 1983 Dec;141(2):81-8
pubmed: 6662146
J Am Diet Assoc. 1984 May;84(5):555-9
pubmed: 6715752
J Am Diet Assoc. 1996 Jul;96(7):680-5
pubmed: 8675911
Clin Orthop Relat Res. 1997 Feb;(335):335-42
pubmed: 9020236
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258

Auteurs

Philipp Egenolf (P)

Faculty of Medicine and University Hospital Cologne, Department of Pediatrics, University of Cologne, Cologne, Germany.

Ibrahim Duran (I)

Faculty of Medicine and University Hospital Cologne, Center for Prevention and Rehabilitation, University of Cologne, Unireha, Cologne, Germany.

Christina Stark (C)

Faculty of Medicine and University Hospital Cologne, Department of Pediatrics, University of Cologne, Cologne, Germany.

Kyriakos Martakis (K)

Faculty of Medicine and University Hospital Cologne, Department of Pediatrics, University of Cologne, Cologne, Germany.
Department of International Health, CAPHRI, FHML, Maastricht University, Maastricht, The Netherlands.

Stefanie Hamacher (S)

Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.

Eckhard Schoenau (E)

Faculty of Medicine and University Hospital Cologne, Department of Pediatrics, University of Cologne, Cologne, Germany.
Faculty of Medicine and University Hospital Cologne, Center for Prevention and Rehabilitation, University of Cologne, Unireha, Cologne, Germany.

Oliver Semler (O)

Faculty of Medicine and University Hospital Cologne, Department of Pediatrics, University of Cologne, Cologne, Germany. joerg.semler@uk-koeln.de.
Children's and Adolescent's Hospital, University of Cologne, Kerpener Str. 62, 50931, Cologne, Germany. joerg.semler@uk-koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH